LBA02: Late-Breaking Abstracts II - Cancer

Podium Session Moderator(s)

• CB

  Clinton Bahler, MD, MS

  Indiana University
• 

  Surena Matin, MD (he/him/his)

  Professor
  MD Anderson Cancer Center

Presentations:

• 1:00 PM – 1:10 PM CST

  LBA02-01: Biochemical recurrence of localized prostate cancer originating from the transition versus peripheral zone: a systematic review and meta-analysis
  

  Podium Presenter: Shijie Jin
• 1:10 PM – 1:20 PM CST

  LBA02-02: A Prospective Study Comparing PENK Methylation, NMP22, and Cytology for Detecting Bladder Cancer Recurrence after Transurethral Resection
  

  Podium Presenter: Youngheun Jo, MD (he/him/his)
• 1:20 PM – 1:30 PM CST

  LBA02-04: Outcomes and Genomic Characteristics of Newly Diagnosed High Grade Ta Papillary Urothelial Carcinoma Treated with Intravesical Chemotherapy vs Bacillus Calmette Guerin (BCG): A Comparative Study During the BCG Shortage
  

  Podium Presenter: Song Jiang
• 1:30 PM – 1:40 PM CST

  LBA02-05: Defining Innate Immune Memory in the Mechanism of BCG Immunotherapy for Bladder Cancer
  

  Podium Presenter: Song Jiang
• 1:40 PM – 1:50 PM CST

  LBA02-06: Psycho-social Distress and Quality of Life in Patients after Radical Cystectomy – One Year Follow-Up in 842 German Patients
  

  Podium Presenter: Henning Bahlburg, MD (he/him/his) – Marienhospital Herne, Urological Clinic
• 1:50 PM – 2:00 PM CST

  LBA02-07: Sex-Dependent Distribution of Pathogenic Germline Variants in Bladder Cancer: A Population-Based Analysis of 400,000 Individuals
  

  Podium Presenter: Danly O. Omil-Lima, MD
• 2:00 PM – 2:10 PM CST

  LBA02-08: Results from the extended follow-up in patients with muscle-invasive bladder cancer in the CheckMate 274 trial
  

  Podium Presenter: Matthew I. Milowsky, MD
• 2:10 PM – 2:20 PM CST

  LBA02-10: Accuracy of a Simplified Sequencing and Bioinformatics Platform on Genetic Variant Detection in Prostate Cancer Patients
  

  Podium Presenter: Deepak Amrit Kapoor, MD – Integrated Medical Professionals, PLLC
• 2:20 PM – 2:30 PM CST

  LBA02-11: Updated Progression-Free Survival from PRESTO: a Phase 3 Randomized Study of Androgen Annihilation for High-Risk Biochemically Relapsed Prostate Cancer (AFT-19)
  

  Podium Presenter: Scott E. Eggener, MD
• 2:30 PM – 2:40 PM CST

  LBA02-12: Is learning curve important while performing PSMA-PET? Analysis of detection rate according to Gleason score and PSA level in two timeframes at a Brazilian high-volume center
  

  Podium Presenter: Paulo Lages, MD
• 2:40 PM – 2:50 PM CST

  LBA02-03: First Results From SunRISe-1 in Patients With BCG Unresponsive High-Risk Non–muscle-Invasive Bladder Cancer Receiving TAR-200 in Combination With Cetrelimab, TAR-200, or Cetrelimab Alone
  

  Podium Presenter: Siamak Daneshmand, MD – Usc Department Of Urology